Clinical trials for breast cancer
87 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Breast cancer
#NCT05501886
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Hormone therapy
Targeted therapy
Hormone therapy
Targeted therapy
Chemotherapy
Systemic Treatment-Naive
Antibody Drug Conjugates (ADC)
Institut Bergonié (Bordeaux), Centre François Baclesse (Caen ), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Celcuity, Inc
Phase 3
Breast cancer
#NCT05038735
HER2 Negative
HR Positive
Locally Advanced
Metastatic
PIK3CA
Hormone therapy
Targeted therapy
Hormone therapy
Targeted therapy
Systemic Treatment-Naive
Hôpital Privé Clairval - Ramsay Santé (Marseille), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Jean Perrin (Clermont Ferrand ), Centre Léon Bérard (Lyon), Hôpital Saint Louis AP-HP (Paris) (and 5 more...)
Novartis
Phase 3
Breast cancer
#NCT04873362
HER2 Positive
Locally Advanced
Localized
Chemotherapy
Targeted therapy
Chemotherapy
Targeted therapy
Immunotherapy
Immunotherapy
Groupe Hospitalier Diaconesses - Site Croix Saint Simon (Paris), Centre Léon Bérard (Lyon), Groupe Hospitalier Public du Sud de l'Oise (Creil), Centre Hospitalier Universitaire de Besançon (Besançon), Institut Sainte Catherine (Avignon) (and 3 more...)
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT05382299
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Systemic Treatment-Naive
PDL1 Negative (< 1%)
Institut Sainte Catherine (Avignon), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre François Baclesse (Caen ), Centre Jean Perrin (Clermont Ferrand ) (and 5 more...)
Gilead Sciences
Phase 3
Breast cancer
#NCT05382299
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Immunotherapy
Systemic Treatment-Naive
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
Institut Sainte Catherine (Avignon), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre François Baclesse (Caen ), Centre Jean Perrin (Clermont Ferrand ) (and 6 more...)
Gilead Sciences
Phase 3
Breast cancer
#NCT04964934
HER2 Negative
HR Positive
Locally Advanced
Metastatic
ESR
Hormone therapy
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier d'Avignon (Avignon), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire Dupuytren (Limoges), Groupe Hospitalier Bretagne Sud - Site de Lorient (Lorient) (and 11 more...)
AstraZeneca
Phase 3
Breast cancer
#NCT05552001
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire Dupuytren (Limoges), Gustave Roussy (Villejuif)
Institut Gustave Roussy
Phase 3
Breast cancer
#NCT03878342
HER2 Low
HER2 Negative
HR Positive
Localized
Surgery
Hormone therapy
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier), Institut Curie - Paris (Paris), Gustave Roussy (Villejuif) (and 25 more...)
UNICANCER
Phase 3
Breast cancer
#NCT05078047
HER2 Negative
HR Negative
Metastatic
Immunotherapy
Institut Sainte Catherine (Avignon), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Henri-Mondor AP-HP (Créteil) (and 16 more...)
UNICANCER
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
#NCT03767075
Locally Advanced
Metastatic
Metastatic Castration-resistant
Systemic Treatment-Naive
Gustave Roussy (Villejuif)
Institut d'oncologie du Vall d'Hebron